Micron Technology Inc

Here is Eli Lilly’s competitive edge in GLP-1 obesity drugs and Abbott’s secondary play

[ad_1] Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in…